Dynamic Technology Lab Private Ltd Makes New $1.94 Million Investment in Amdocs Limited $DOX

Dynamic Technology Lab Private Ltd bought a new position in Amdocs Limited (NASDAQ:DOX) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 21,299 shares of the technology company’s stock, valued at approximately $1,943,000.

Several other hedge funds have also made changes to their positions in the company. Pzena Investment Management LLC grew its position in Amdocs by 2.1% during the 2nd quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock worth $597,719,000 after purchasing an additional 132,463 shares in the last quarter. LSV Asset Management lifted its holdings in shares of Amdocs by 6.6% in the second quarter. LSV Asset Management now owns 3,391,510 shares of the technology company’s stock valued at $309,441,000 after purchasing an additional 211,009 shares in the last quarter. Alyeska Investment Group L.P. boosted its position in shares of Amdocs by 38.6% in the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after buying an additional 648,693 shares during the period. American Century Companies Inc. grew its holdings in shares of Amdocs by 23.5% during the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock valued at $205,219,000 after buying an additional 426,911 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Amdocs by 9.4% during the first quarter. Dimensional Fund Advisors LP now owns 2,120,075 shares of the technology company’s stock valued at $193,978,000 after buying an additional 182,489 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Down 0.8%

Shares of Amdocs stock opened at $75.39 on Thursday. The firm has a market cap of $8.51 billion, a price-to-earnings ratio of 15.29, a P/E/G ratio of 1.40 and a beta of 0.51. The stock has a 50-day simple moving average of $82.45 and a 200-day simple moving average of $86.98. Amdocs Limited has a 52-week low of $74.32 and a 52-week high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.82 by $0.01. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company’s revenue for the quarter was down 9.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. On average, equities research analysts expect that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a $0.527 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.8%. Amdocs’s dividend payout ratio is currently 41.58%.

Analysts Set New Price Targets

Several brokerages recently issued reports on DOX. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Stifel Nicolaus decreased their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Bank of America dropped their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Amdocs has an average rating of “Moderate Buy” and a consensus price target of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.